Insufficient scRNA-seq data for expression of ASZ1 at single-cell level.
Insufficient scRNA-seq data for expression of ASZ1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 0% | 0 | 0 / 578 | 4% | 0.18 | 45 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.56 | 1 / 29 |
prostate | 0% | 0.57 | 1 / 245 | 2% | 0.12 | 11 / 502 |
breast | 0% | 0 | 0 / 459 | 2% | 0.07 | 17 / 1118 |
esophagus | 0% | 0.07 | 1 / 1445 | 1% | 0.07 | 2 / 183 |
liver | 0% | 0 | 0 / 226 | 1% | 0.03 | 4 / 406 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.03 | 2 / 230 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.02 | 2 / 286 |
skin | 0% | 0 | 0 / 1809 | 1% | 0.01 | 3 / 472 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 1 / 178 |
uterus | 0% | 0 | 0 / 170 | 0% | 0.01 | 2 / 459 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.01 | 2 / 504 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 3 / 901 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.00 | 1 / 527 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.01 | 1 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010526 | Biological process | retrotransposon silencing |
GO_0007283 | Biological process | spermatogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0031047 | Biological process | regulatory ncRNA-mediated gene silencing |
GO_0007140 | Biological process | male meiotic nuclear division |
GO_0071546 | Cellular component | pi-body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | ASZ1 |
Protein name | Ankyrin repeat, SAM and basic leucine zipper domain containing 1 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Ankyrin-like protein 1) (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) |
Synonyms | ALP1 hCG_15953 ANKL1 C7orf7 GASZ |
Description | FUNCTION: Plays a central role during spermatogenesis by repressing transposable elements and preventing their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Its association with pi-bodies suggests a participation in the primary piRNAs metabolic process. Required prior to the pachytene stage to facilitate the production of multiple types of piRNAs, including those associated with repeats involved in the regulation of retrotransposons. May act by mediating protein-protein interactions during germ cell maturation (By similarity). . FUNCTION: Plays a central role during spermatogenesis by repressing transposable elements and preventing their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Its association with pi-bodies suggests a participation in the primary piRNAs metabolic process. Required prior to the pachytene stage to facilitate the production of multiple types of piRNAs, including those associated with repeats involved in the regulation of retrotransposons. May act by mediating protein-protein interactions during germ cell maturation. . |
Accessions | ENST00000284629.7 [Q8WWH4-1] Q49AP3 C9JP59 F8WDQ2 ENST00000428663.1 Q8WWH4 ENST00000450714.2 |